Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2026)

Maravai Lifesciences Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$203000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 97.61% year-over-year to -$203000.0 in Q1 2026; TTM through Mar 2026 was -$10.3 million, a 24.16% increase from a year earlier, with the FY2025 full-year figure at -$18.6 million, down 195.78% from the prior year.
• Other Working Capital Changes advanced to -$203000.0 in Q1 2026 per MRVI's latest filing, from -$1.9 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $26.3 million in Q3 2022 and bottomed at -$21.3 million in Q2 2023.
• The 5-year median for Other Working Capital Changes is -$439000.0 (2024), against an average of $2.0 million.
• Biggest YoY gain for Other Working Capital Changes was 12217.19% in 2025; the steepest drop was 638.26% in 2025.
• Year by year, Other Working Capital Changes stood at -$2.7 million in 2022, then jumped by 40.04% to -$1.6 million in 2023, then rose by 29.88% to -$1.2 million in 2024, then slumped by 64.61% to -$1.9 million in 2025, then soared by 89.28% to -$203000.0 in 2026.
• Per Business Quant, the three latest MRVI Other Working Capital Changes figures stand at -$203000.0 (Q1 2026), -$1.9 million (Q4 2025), and -$16.0 million (Q3 2025).